9 Meters Biopharma FY 2021: net loss $36.8M; diluted EPS −$3.00

Key figures from this report

These are the numbers 9 Meters Biopharma reported for the year ended Dec 31, 2021, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Net income−$36.8MAgainst −$61.5M in FY 202010-K income statement, on EDGAR
2. Diluted EPS−$3.00Against −$11.60 in FY 2020. Split-adjusted, as the tables show it; the filing reported −$0.1510-K income statement, on EDGAR
3. Cash and cash equivalents$47.0M+24% from $37.9M in FY 202010-K balance sheet, on EDGAR
4. Cash from operations−$29.5MAgainst −$19.4M in FY 202010-K cash flow statement, on EDGAR